45

Shionogi

- TYO:4507
Last Updated 2024-04-16

LinkedIn Profile

Access Shionogi historical Linkedin company profile data on number of followers, employee headcount and more

Rows

Open dataset
Ticker Symbol Entity Name As Of Date Company Name Followers Employees on Linkedin Link Industry Date Added Date Updated Description Website Specialities Logo HQ.Street HQ.City HQ.State HQ.Country HQ.Postal Headcount change in past 24 months Company Name Sector Industry
tyo:4507 2134473 Apr 14th, 2024 12:00AM Shionogi Inc. (U.S.) 16K 503.00 Open Apr 14th, 2024 06:23AM Apr 14th, 2024 06:23AM Since 1878, we have been committed to developing new treatments to improve patients' lives worldwide. We are helping to address global health challenges such as antimicrobial resistance and COVID-19. Since the 1950s, we have discovered and introduced several novel antibiotics, as well as innovative medications for HIV and influenza. Today, we are developing an investigational oral antiviral for COVID-19 and advancing clinical programs in Fragile X syndrome, acute ischemic stroke as well metabolic disorders and oncology. Our team is driven to impact patient lives. Our partnerships with industry, government agencies, biotech companies and academia help to advance science with the urgency that today's health challenges demand. Through a combination of in-house discovery and strategic partnerships, we continue to deliver firsts for patients in the U.S. and worldwide. Open Open 300 Campus Drive Florham Park New Jersey US 07932 Shionogi Health Care Pharmaceuticals & Biotechnology
tyo:4507 2134473 Apr 13th, 2024 12:00AM Shionogi Inc. (U.S.) 16K 501.00 Open Apr 13th, 2024 05:16AM Apr 13th, 2024 05:17PM Since 1878, we have been committed to developing new treatments to improve patients' lives worldwide. We are helping to address global health challenges such as antimicrobial resistance and COVID-19. Since the 1950s, we have discovered and introduced several novel antibiotics, as well as innovative medications for HIV and influenza. Today, we are developing an investigational oral antiviral for COVID-19 and advancing clinical programs in Fragile X syndrome, acute ischemic stroke as well metabolic disorders and oncology. Our team is driven to impact patient lives. Our partnerships with industry, government agencies, biotech companies and academia help to advance science with the urgency that today's health challenges demand. Through a combination of in-house discovery and strategic partnerships, we continue to deliver firsts for patients in the U.S. and worldwide. Open Open 300 Campus Drive Florham Park New Jersey US 07932 Shionogi Health Care Pharmaceuticals & Biotechnology
tyo:4507 2134473 Apr 12th, 2024 12:00AM Shionogi Inc. (U.S.) 16K 501.00 Open Apr 12th, 2024 05:30AM Apr 12th, 2024 02:25PM Since 1878, we have been committed to developing new treatments to improve patients' lives worldwide. We are helping to address global health challenges such as antimicrobial resistance and COVID-19. Since the 1950s, we have discovered and introduced several novel antibiotics, as well as innovative medications for HIV and influenza. Today, we are developing an investigational oral antiviral for COVID-19 and advancing clinical programs in Fragile X syndrome, acute ischemic stroke as well metabolic disorders and oncology. Our team is driven to impact patient lives. Our partnerships with industry, government agencies, biotech companies and academia help to advance science with the urgency that today's health challenges demand. Through a combination of in-house discovery and strategic partnerships, we continue to deliver firsts for patients in the U.S. and worldwide. Open Open 300 Campus Drive Florham Park New Jersey US 07932 Shionogi Health Care Pharmaceuticals & Biotechnology
tyo:4507 2134473 Apr 11th, 2024 12:00AM Shionogi Inc. (U.S.) 16K 501.00 Open Apr 11th, 2024 07:32AM Apr 11th, 2024 05:12PM Since 1878, we have been committed to developing new treatments to improve patients' lives worldwide. We are helping to address global health challenges such as antimicrobial resistance and COVID-19. Since the 1950s, we have discovered and introduced several novel antibiotics, as well as innovative medications for HIV and influenza. Today, we are developing an investigational oral antiviral for COVID-19 and advancing clinical programs in Fragile X syndrome, acute ischemic stroke as well metabolic disorders and oncology. Our team is driven to impact patient lives. Our partnerships with industry, government agencies, biotech companies and academia help to advance science with the urgency that today's health challenges demand. Through a combination of in-house discovery and strategic partnerships, we continue to deliver firsts for patients in the U.S. and worldwide. Open Open 300 Campus Drive Florham Park New Jersey US 07932 Shionogi Health Care Pharmaceuticals & Biotechnology
tyo:4507 2134473 Apr 10th, 2024 12:00AM Shionogi Inc. (U.S.) 16K 501.00 Open Apr 10th, 2024 05:17AM Apr 11th, 2024 12:39AM Since 1878, we have been committed to developing new treatments to improve patients' lives worldwide. We are helping to address global health challenges such as antimicrobial resistance and COVID-19. Since the 1950s, we have discovered and introduced several novel antibiotics, as well as innovative medications for HIV and influenza. Today, we are developing an investigational oral antiviral for COVID-19 and advancing clinical programs in Fragile X syndrome, acute ischemic stroke as well metabolic disorders and oncology. Our team is driven to impact patient lives. Our partnerships with industry, government agencies, biotech companies and academia help to advance science with the urgency that today's health challenges demand. Through a combination of in-house discovery and strategic partnerships, we continue to deliver firsts for patients in the U.S. and worldwide. Open Open 300 Campus Drive Florham Park New Jersey US 07932 Shionogi Health Care Pharmaceuticals & Biotechnology
tyo:4507 2134473 Apr 9th, 2024 12:00AM Shionogi Inc. (U.S.) 16K 501.00 Open Apr 9th, 2024 05:40AM Apr 9th, 2024 03:49PM Since 1878, we have been committed to developing new treatments to improve patients' lives worldwide. We are helping to address global health challenges such as antimicrobial resistance and COVID-19. Since the 1950s, we have discovered and introduced several novel antibiotics, as well as innovative medications for HIV and influenza. Today, we are developing an investigational oral antiviral for COVID-19 and advancing clinical programs in Fragile X syndrome, acute ischemic stroke as well metabolic disorders and oncology. Our team is driven to impact patient lives. Our partnerships with industry, government agencies, biotech companies and academia help to advance science with the urgency that today's health challenges demand. Through a combination of in-house discovery and strategic partnerships, we continue to deliver firsts for patients in the U.S. and worldwide. Open Open 300 Campus Drive Florham Park New Jersey US 07932 Shionogi Health Care Pharmaceuticals & Biotechnology
tyo:4507 2134473 Apr 8th, 2024 12:00AM Shionogi Inc. (U.S.) 16K 501.00 Open Apr 8th, 2024 06:12AM Apr 8th, 2024 06:12AM Since 1878, we have been committed to developing new treatments to improve patients' lives worldwide. We are helping to address global health challenges such as antimicrobial resistance and COVID-19. Since the 1950s, we have discovered and introduced several novel antibiotics, as well as innovative medications for HIV and influenza. Today, we are developing an investigational oral antiviral for COVID-19 and advancing clinical programs in Fragile X syndrome, acute ischemic stroke as well metabolic disorders and oncology. Our team is driven to impact patient lives. Our partnerships with industry, government agencies, biotech companies and academia help to advance science with the urgency that today's health challenges demand. Through a combination of in-house discovery and strategic partnerships, we continue to deliver firsts for patients in the U.S. and worldwide. Open Open 300 Campus Drive Florham Park New Jersey US 07932 Shionogi Health Care Pharmaceuticals & Biotechnology
tyo:4507 2134473 Apr 7th, 2024 12:00AM Shionogi Inc. (U.S.) 16K 501.00 Open Apr 7th, 2024 05:48AM Apr 7th, 2024 09:18PM Since 1878, we have been committed to developing new treatments to improve patients' lives worldwide. We are helping to address global health challenges such as antimicrobial resistance and COVID-19. Since the 1950s, we have discovered and introduced several novel antibiotics, as well as innovative medications for HIV and influenza. Today, we are developing an investigational oral antiviral for COVID-19 and advancing clinical programs in Fragile X syndrome, acute ischemic stroke as well metabolic disorders and oncology. Our team is driven to impact patient lives. Our partnerships with industry, government agencies, biotech companies and academia help to advance science with the urgency that today's health challenges demand. Through a combination of in-house discovery and strategic partnerships, we continue to deliver firsts for patients in the U.S. and worldwide. Open Open 300 Campus Drive Florham Park New Jersey US 07932 Shionogi Health Care Pharmaceuticals & Biotechnology
tyo:4507 2134473 Apr 7th, 2024 12:00AM Shionogi Inc. (U.S.) 16K 501.00 Open Apr 7th, 2024 05:48AM Apr 7th, 2024 05:48AM Since 1878, we have been committed to developing new treatments to improve patients' lives worldwide. We are helping to address global health challenges such as antimicrobial resistance and COVID-19. Since the 1950s, we have discovered and introduced several novel antibiotics, as well as innovative medications for HIV and influenza. Today, we are developing an investigational oral antiviral for COVID-19 and advancing clinical programs in Fragile X syndrome, acute ischemic stroke as well metabolic disorders and oncology. Our team is driven to impact patient lives. Our partnerships with industry, government agencies, biotech companies and academia help to advance science with the urgency that today's health challenges demand. Through a combination of in-house discovery and strategic partnerships, we continue to deliver firsts for patients in the U.S. and worldwide. Open Open 300 Campus Drive Florham Park New Jersey US 07932 Shionogi Health Care Pharmaceuticals & Biotechnology
tyo:4507 2134473 Apr 6th, 2024 12:00AM Shionogi Inc. (U.S.) 16K 500.00 Open Apr 6th, 2024 05:29AM Apr 6th, 2024 05:29AM Since 1878, we have been committed to developing new treatments to improve patients' lives worldwide. We are helping to address global health challenges such as antimicrobial resistance and COVID-19. Since the 1950s, we have discovered and introduced several novel antibiotics, as well as innovative medications for HIV and influenza. Today, we are developing an investigational oral antiviral for COVID-19 and advancing clinical programs in Fragile X syndrome, acute ischemic stroke as well metabolic disorders and oncology. Our team is driven to impact patient lives. Our partnerships with industry, government agencies, biotech companies and academia help to advance science with the urgency that today's health challenges demand. Through a combination of in-house discovery and strategic partnerships, we continue to deliver firsts for patients in the U.S. and worldwide. Open Open 300 Campus Drive Florham Park New Jersey US 07932 Shionogi Health Care Pharmaceuticals & Biotechnology

Request a demo to view additional historical data, and much more.

Request Demo

Make fast
queries

No longer rely on engineers to access data; build and share queries with intuitive tools, and derive insights in real time.

Bookmark queries with your team

Save and share custom queries using a private bookmarking feature, accessible to your whole team.

Be first to know with alerts

Scan data points across millions of companies and receive emails when relevant metrics cross critical thresholds.

Visualize data for quick insights

Create custom keyword-based word clouds, charts, and advanced visualizations to quickly analyze the data.

Map competitor locations

Analyze competitor presence and growth over time by overlaying store locations with the Nearby Competitor feature.

Add widgets to your dashboards

Access existing maps, charts, word clouds, and other visualizations to understand your data quickly. Or build custom widgets to view data just the way you want it.